A. SCOPE OF THEPROBLEM
- drugs can adversely affect all body systems in varying degrees of
intensity
- mild reactions include drowsiness, nausea, itching, and rash
- severe reactions include respiratory depression, neutropenia (profound
loss of neutrophilic white blood
cells, hepatocellular injury, anaphylaxis, and hemorrhage – all of
which can result in death
- adverse effects are most common in the elderly and very young
- severe illness also increases the risk of an ADR
- adverse events are more common in patients receiving multiple drugs
B. DEFINITIONS
1. Hepatotoxic Drugs
- drugs are the leading cause of acute liver (primary site of drug
metabolism) failure, a rare
condition that can rapidly prove fatal (most cases end with a
liver transplant or in
death)
- as some drugs undergo metabolism, they are converted to toxic
products that can injure liver
cells (most common reason for withdrawing drugs from the
market)
- signs of liver injury include jaundice (yellow skin and eyes), dark
urine, light-colored stools,
nausea, vomiting, malaise, abdominal discomfort, loss of
appetite
- patients taking hepatotoxic drugs should undergo liver function
tests (LFTs) at baseline and
periodically thereafter
- ex. Combination of acetaminophen (Tylenol, others) with alcohol
Indicators:
Did symptoms appear shortly after the drug was first used?
Did symptoms abate when the drug was discontinued?
Did symptoms reappear when the drug was reinstated?
Is the illness itself sufficient to explain the event?
Are other drugs in the regimen sufficient to explain the event?
F. MEDICATION ERRORS
- EVERYONE MAKES MEDICATION ERRORS
System of Reduction:
Institutional Culture – establish an organizational commitment to a
culture of safety
- provide medication safety education for all professional
employees
- maintain ongoing recognition of safety innovation
- encourage identification of errors and develop new patient
safety systems
Infrastructure – designate a medication safety coordinator/officer
- promote greater use of clinical pharmacists in high-risk areas
- establish area-specific guidelines for unit-stocked
medications
- establish a mechanism to ensure availability of critical
medication information to all
members of patient’s care team
Clinical Practice – eliminate dangerous abbreviations and dose
designations
- implement safety checklists for high-alert medications and
infusion pumps
- develop limitations and safeguards regarding verbal orders
- perform failure-mode analysis during procurement process
- implement triggers and markers to indicate potential adverse
medication events
Technology – eliminate the use of infusion pumps that lack free-flow
protection
- prepare for implementation of computerized prescriber order
entry system